4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-036270
Chief Development Officer gave up 14,136 shares (to pay taxes)
- Chief Development Officer acquired 58,050 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hammond Janet MJ Chief Development Officer | 2026-01-31 | Option exercise | +58,050 | 141,801 | D: show line 1 in the form | ||
| Hammond Janet MJ Chief Development Officer | 2026-01-31 | Shares withheld for taxes | −14,136 | $4.24 | $59,937 | 127,665 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Hammond Janet MJ Chief Development Officer | 2026-01-31 | Option exercise · Restricted Stock Units | −46,800 | 0 | D: show line 3 in the form | |||||
| Hammond Janet MJ Chief Development Officer | 2026-01-31 | Option exercise · Restricted Stock Units | −11,250 | 0 | D: show line 4 in the form | |||||
| Hammond Janet MJ Chief Development Officer | 2026-01-31 | Grant or award · Stock Option (Right to Buy) | +177,000 | 177,000 | D: show line 5 in the form |
Loading xslF345X05/ownership.xml…